Chiron Real Estate Inc.

What they do

Chiron Real Estate Inc. (NYSE: XRN) is a REIT that primarily acquires healthcare facilities leased to physician groups and regional or national healthcare systems under triple-net leases. Its portfolio includes medical office buildings, inpatient rehabilitation facilities, surgical hospitals, and other properties, along with a recently launched seniors housing operating (SHOP) segment. As of December 31, 2025, the company owned 189 buildings with approximately 5.1 million leasable square feet and $118.8 million in annualized base rent.

Revenue drivers

• Medical Office Buildings (MOB) — Largest segment, comprising 79.1% of leasable square feet (4.0 million) and 71.9% of annualized base rent ($85.4 million) as of December 31, 2025. Rents are primarily collected under triple-net leases from single tenants.
• Inpatient Rehabilitation Facilities (IRF) — Second-largest segment, representing 10.1% of leasable square feet (515,119) and 16.5% of annualized base rent ($19.6 million) as of December 31, 2025.
• Surgical Hospitals — Smaller segment, accounting for 2.1% of leasable square feet (108,674) and 3.7% of annualized base rent ($4.4 million) as of December 31, 2025.
• Seniors Housing Operating Portfolio (SHOP) — Newly launched segment as of Q2 2026, consisting of two communities with 292 homes (The Landing and The Riviera) in Alexandria, Virginia. These are operated, not triple-net leased, generating revenue from resident fees.

Recent performance

For Q2 2026, the company reported net income attributable to common stockholders of $63.3 million, or $4.78 per diluted share, versus a net loss of $0.8 million, or $0.06 per diluted share, in the prior-year quarter. Quarterly FFO was $0.88 per share and unit, and Core FFO was $1.04 per share and unit, down from $0.98 and $1.14, respectively, in the prior-year period. Same-property cash NOI growth for the Outpatient Medical portfolio was +0.8% year-over-year, or +1.7% excluding a one-time recovery in the prior year. For fiscal 2025, the company reported a net loss of $6.9 million (-$0.91 diluted EPS) on revenue of $148.2 million.

Strategy

Management is actively repositioning the portfolio, focusing primarily on seniors housing properties (SHOP) while monetizing legacy healthcare assets. In Q2 2026, the company completed its inaugural SHOP acquisitions (The Landing and The Riviera) and sold legacy assets, redeploying capital into what it believes are higher-return investments. The company also strengthened its leadership team with new executives, including a Chief Investment Officer and a Head of Seniors Housing, adding over 100 years of senior housing expertise. The company completed a one-for-five reverse stock split in September 2025 and changed its name from Global Medical REIT Inc. to Chiron Real Estate Inc. in February 2026.

Risks

• Tenant concentration — The company is dependent on tenants for revenue, and the inability of any significant tenant to pay rent could have a disproportionate negative impact.
• Single-tenant properties — Most facilities are single-tenant; finding suitable replacement tenants could be difficult, especially in smaller markets, in case of default or non-renewal.
• Interest rate exposure — The company uses unhedged floating-rate debt from its Credit Facility, and higher interest rates since 2022 have materially increased interest costs.
• SHOP operational risks — The new SHOP segment exposes the company to operational risks, liabilities, and reliance on third-party managers, with no guarantee of favorable renewal terms.

Outlook

Management expects The Landing and The Riviera SHOP communities to deliver a yield on cost greater than 7% upon stabilization in the second half of 2028. The Landing was 93% occupied as of June 30, 2026 (96% by July 31), while The Riviera was 23% occupied (26% by July 31) during its initial lease-up period. The company continues to execute on its portfolio repositioning, expecting to redeploy capital from legacy asset sales into seniors housing and other investments.